Matinas BioPharma Holdings (MTNB) Cash from Operations Growth (5y) (2018 - 2026)
Matinas BioPharma Holdings (MTNB) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.25% |
| Mar 31, 2026 | 19.21% |
| Dec 31, 2025 | 18.92% |
| Sep 30, 2025 | 22.37% |
| Jun 30, 2025 | 8.60% |
| Mar 31, 2025 | 15.52% |
| Dec 31, 2024 | 6.45% |
| Sep 30, 2024 | 2.99% |
| Jun 30, 2024 | -8.18% |
| Mar 31, 2024 | -13.80% |
| Dec 31, 2023 | -11.82% |
| Sep 30, 2023 | -10.87% |
| Jun 30, 2023 | 0.59% |
| Mar 31, 2023 | -7.81% |
| Dec 31, 2022 | -17.55% |
| Sep 30, 2022 | -12.28% |
| Jun 30, 2022 | -6.60% |
| Mar 31, 2022 | -9.42% |
| Dec 31, 2021 | -13.34% |
| Sep 30, 2021 | -33.30% |